Original articleHealth status and hypertension: A population-based study☆,☆☆
References (34)
Hoerr's law
Am J Surg
(1962)- et al.
Hypertension labeling and well-being: Alternative explanations in cross-sectional data
J Chron Dis
(1984) - et al.
The Beaver Dam Eye Study: Visual acuity
Ophthalmology
(1991) - et al.
Methodology for measurement of health-state preferences. II. Scaling methods
J Clin Epidemiol
(1989) - et al.
The utility of different health states as perceived by the general public
J Chron Dis
(1978) - et al.
Blood pressure, stroke, and coronary heart disease. 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
Lancet
(1990) - et al.
Increased absenteeism from work after detection and labelling of hypertensive patients
N Engl J Med
(1978) The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V)
Arch Intern Med
(1993)- et al.
The effects of antihypertensive therapy on the quality of life
N Engl J Med
(1986) - et al.
Hypertensive black men and women: Quality of life and effects of antihypertensive medications
Arch Intern Med
(1990)
A randomized controlled trial of three antihypertensive agents on blood pressure control and quality of life in older women
Arch Intern Med
Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system
Am J Hypertens
Quality of life and antihypertensive therapy in men: A comparison of captopril with enalapril
N Engl J Med
Treatment of hypertension in the elderly. II. Cognitive and behavioral function: Results of a Veterans Affairs Cooperative Study
Hypertension
Effect of antihypertensives on sexual function and quality of life: The TAIM Study
Ann Intern Med
The Treatment of Mild Hypertension Study: A randomized, placebo controlled trial of a nutritional-hygienic regimen along with various drug monotherapies
Arch Intern Med
Treatment of Mild Hypertension Study: Final results
JAMA
Cited by (101)
Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction
2016, Journal of the American Society of HypertensionCitation Excerpt :Patients eligible for inclusion were identified in the ED using the facility's electronic medical record (FirstNet by Cerner Corp.; Kansas City, MO, USA). Patients 35 years of age or older who had an initial and repeat (within 1 hour) BP >140/90 mm Hg and normal exertional tolerance (defined as class 1 on the Goldman Specific Activity Scale) were eligible for inclusion.25,26 Patients with acute illness requiring hospitalization, a prior history of cardiac disease, or any presentation with symptoms potentially attributable to hypertensive heart disease (eg, dyspnea, chest pain) were excluded.
Blood pressure control and perceived health status in African Americans with subclinical hypertensive heart disease
2014, Journal of the American Society of HypertensionACCF/AHA 2011 expert consensus document on hypertension in the elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents Developed in Collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology,
2011, Journal of the American Society of HypertensionTransforming growth factor-β1 in essential hypertension
2011, Revista del Laboratorio ClinicoACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the American college of cardiology foundation task force on clinical expert consensus documents
2011, Journal of the American College of Cardiology
- ☆
This paper was presented in part at the Sixteenth Annual Meeting of the Society of General Internal Medicine, Arlington, Virginia, April 1993, and at the Fifteenth Annual Meeting of the Society for Medical Decision Making, Research Triangle Park, North Carolina, October 1993.
- ☆☆
This project is supported by Grant No. HS 06491 from the Agency for Health Care Policy and Research, and National Eye Institute Grant 10U06594.